HOWL — WEREWOLF THERAPEUTICS INC

Ownership history in DC Funds, LP  ·  19 quarters on record

This page tracks every 13F SEC filing in which DC Funds, LP reported a position in WEREWOLF THERAPEUTICS INC (HOWL). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
40.97% (2021 Q4)
Avg. % of fund
32.26%
First filed
2021 Q2
Last filed
2025 Q4
Quarters held
19
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 589,102 — 0% 25.69% $373.2M $0.63
2025 Q3 UNCHANGED 589,102 — 0% 37.32% $1.16B $1.97
2025 Q2 UNCHANGED 589,102 — 0% 29.83% $642.1M $1.09
2025 Q1 UNCHANGED 589,102 — 0% 27.71% $572.7M $0.97
15 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    HOWL price (monthly, adj. close)

Other funds also holding HOWL

As of 2025 Q4 — sorted by position size

MPM BioImpact LLC 3Y 0.1% Lynx1 Capital Management LP 3Y 0.08% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 0.08% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 0.04% Ranch Capital Advisors Inc. 3Y 0.0% HIGHLINE WEALTH PARTNERS LLC 0.0% Regal Investment Advisors LLC 3Y 7Y 0.0% Delta Investment Management, LLC 3Y 7Y 0.0% Financial Perspectives, Inc 0.0% BRIDGEWAY CAPITAL MANAGEMENT, LLC 3Y 7Y 0.0%
← Back to DC Funds, LP Holdings